image dons

je fais un don

Fil infos du Groupe ACTION

INFORMATIONS COVID
+

01/04/2011

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and...
+

25/02/2011

A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study.

A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time o...
+

01/01/2011

Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study.

Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care...
+

01/10/2010

Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial

Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial...
+

01/09/2010

Usefulness of biomarker strategy to improve GRACE score’s prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.

Usefulness of biomarker strategy to improve GRACE score’s prediction performance in patients with non-ST-seg...
+

23/02/2010

Slow response to clopidogrel predicts low response.

Slow response to clopidogrel predicts low response. Publié dans Journal of the Ameri...